NovaBridge Biosciences American Depositary Shares
NBP
49 hedge funds and large institutions have $48.1M invested in NovaBridge Biosciences American Depositary Shares in 2026 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 11 closing their positions.
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
2% more funds holding
Funds holding: 48 → 49 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.09% less ownership
Funds ownership: 25.43% → 21.33% (-4.1%)
33% less capital invested
Capital invested by funds: $72.1M → $48.1M (-$24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.51M |
| 2 |
Two Sigma Investments
New York
|
+$1.74M |
| 3 |
ACM
AIHC Capital Management
Central,
|
+$1.25M |
| 4 |
EFM
E Fund Management
Guangzhou,
China
|
+$1.2M |
| 5 |
Renaissance Technologies
New York
|
+$991K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.42M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$2.03M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$714K |
| 4 |
Morgan Stanley
New York
|
-$377K |
| 5 |
HF
HRT Financial
New York
|
-$264K |
NBP Hedge Fund Activity: Q2 2026 in Review
49 of the 8,330 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2026, worth a combined $48.1M — down 33% from $72.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NBP positions and 11 closed out — a net gain of 2 holders — while 13 added to existing stakes and 11 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $2.51M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.42M sold.
- 49 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2026, up from 48 in Q1 2026.
- Funds reported $48.1M of NovaBridge Biosciences American Depositary Shares stock for Q2 2026, down 33% quarter-over-quarter.
- 13 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2026 and 11 closed out, a net change of +2 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2026 was Marshall Wace, an estimated $2.51M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2026 was Point72 Asset Management, an estimated $3.42M sold.
Based on aggregated 13F filings for Q2 2026.